Article Figures & Data
Tables
Characteristic Total
No. (%)Groups (n = 60 per group) P Value Control
No. (%)Intervention
No. (%)Age, y <40 10 (8.4) 5 (8.3) 5 (8.3) .980a 40-59 37 (30.8) 19 (31.7) 18 (30.8) ≥60 73 (60.8) 36 (60.0) 37 (60.8) Ethnicity Malay 101 (84.2) 48 (80.0) 53 (88.3) .211a Non-Malay 19 (15.8) 12 (20.0) 7 (11.7) Employment Employed 46 (38.3) 27 (45.0) 19 (31.7) .133a Not employed 74 (61.7) 33 (55.0) 41 (68.3) Education Primary 9 (7.5) 6 (10.0) 3 (5.0) .099b Secondary 79 (65.8) 43 (71.7) 36 (60.0) Tertiary 32 (26.7) 11 (18.3) 21 (35.0) Monthly household income, MYR <3,710 106 (88.4) 53 (88.3) 53 (88.3) .613b 3,710-7549 10 (8.3) 4 (6.7) 6 (10.0) >7,550 4 (3.3) 3 (5.0) 1 (1.7) Marital status Single 7 (5.8) 3 (5.0) 4 (6.7) .786b Married 110 (91.7) 56 (93.3) 54 (90.0) Widower 3 (2.5) 1 (1.7) 2 (3.3) Severity of ED None 28 (23.3) 18 (30.0) 10 (16.7) .098a Mild 38 (31.7) 21 (35.0) 17 (28.3) Moderate 40 (33.3) 14 (23.3) 26 (43.3) Severe 14 (11.7) 7 (11.7) 7 (11.7) - Table 2.
Initiation of Discussion and Prescription of a PDE5 Inhibitor Between Groups (N = 120)
Characteristic Total
No. (%)Groups (n = 60 per group) P Value Control
No. (%)Intervention
No. (%)Initiation of ED discussion (n = 120) Yes 45 (37.5) 5 (8.3) 40 (66.7) <.001a No 75 (62.5) 55 (91.7) 20 (33.3) PDE5 inhibitor prescription (n = 45) Yes 23 (51.1) 0 (0.0) 23 (57.5) .022b No 22 (48.9) 5 (100.0) 17 (42.5) - Table 3.
Simple Logistic Regression of Associated Factors for Initiation of Discussion and Prescription of a PDE5 Inhibitor in the Intervention Group (N = 60)
Characteristic Initiation of Discussion (n = 60) PDE5 Inhibitor Prescription (n = 40) Crude OR (95% CI) P Value Crude OR (95% CI) P Value Age, y <40 Ref … Ref … 40-59 5.25 (0.64-43.13) .123 1.53 (0.13-17.33) .727 ≥60 2.77 (0.41-18.74) .296 3.40 (0.35-33.40) .294 Ethnicity Malay Ref … Ref … Non-Malay 3.35 (0.38-29.96) .279 2.39 (0.48-11.80) .286 Employment Employed Ref … Ref … Not employed 1.26 (0.40-3.93) .695 1.54 (0.49-4.85) .465 Education Primary Ref 1 Ref … Secondary 0.89 (0.73-10.72) .923 1.43 (0.19-17.23) .779 Tertiary 1.25 (0.95-16.50) .865 1.00 (0.08-13.01) 1.000 Monthly household income, MYR <3,710 Ref … Ref … ≥3,710 1.29 (0.23-7.29) .777 0.24 (0.03-2.09) .194 Marital status Married Ref … Ref … Single 2.71 (0.29-24.95) .378 0.29 (0.32-2.66) .274 Severity of ED Mild Ref … Ref … Moderate 1.55 (0.49-4.80) .450 6.00 (1.73-20.82) .004a Severe 4.13 (0.43-39.21) .217 3.30 (0.55-19.65) .190 ED = erectile dysfunction; MYR = Malaysian Ringgit currency; OR = odds ratio; PDE5 = phosphodiesterase-5.
↵a P value <.05
- Table 4.
Use of LASTED on Discussion Satisfaction and Prescription of PDE5 Inhibitors in the Intervention Group (N = 40)
Outcomes Total
No. (%)Use of LASTED P Value Yes (n = 33)
No. (%)No (n = 7)
No. (%)Discussion satisfaction Extremely satisfied 13 (32.5) 13 (39.4) 0 (0.0) <.001b Satisfied 22 (55.0) 20 (60.6) 2 (28.5) Not sure 3 (7.5) 0 (0.0) 3 (42.8) Not satisfied 2 (5.0) 0 (0.0) 2 (28.5) PDE5 inhibitor prescription Yes 23 (57.5) 22 (66.7) 1 (14.3) .011a No 17 (42.5) 11 (33.3) 6 (85.7) Outcomes Total
No. (%)Use of LASTED Yes (n = 33)
No. (%)No (n = 7)
No. (%)Topics discussed Causes of ED 23 (57.5) 17 (51.5) 6 (85.7) Symptoms of ED 16 (40.0) 13 (39.4) 3 (42.9) Severity of ED 12 (30.0) 11 (33.3) 1 (14.3) Treatment of ED 32 (80.0) 28 (84.0) 4 (57.1) Cardiac risk of ED 7 (17.5) 6 (18.2) 1 (14.3) Others 3 (7.5) 3 (9.1) 0 (0.0) Type of treatment discussed Lifestyle 13 (32.5) 10 (30.3) 3 (42.9) Oral medication 35 (87.5) 31 (93.9) 4 (57.1) Vacuum erection device 13 (32.5) 13 (39.4) 0 (0.0) Intracavernous injections 10 (25.0) 10 (30.3) 0 (0.0) Penile prosthesis 6 (15.0) 6 (18.2) 0 (0.0) ED = erectile dysfunction; LASTED = Knowledge Translation Tools in the Management of Erectile Dysfunction.
Additional Files
SUPPLEMENTAL MATERIALS IN PDF FILE BELOW
- Ahmad_Supp_Apps.pdf -
PDF file
- Ahmad_Supp_Apps.pdf -